title: Effect of adding a gonadotropin-releasing-hormone treatment at the beginning and a second prostaglandin F2α treatment at the end of an estradiol-based protocol for timed artificial insemination in lactating dairy cows during cool or hot seasons of the year.
abstract: Our hypothesis was that fertility could be increased in a timed artificial insemination (TAI) protocol based on estradiol (E2) and progesterone (P4) by combining GnRH with E2-benzoate at the start of the protocol to increase circulating P4 during preovulatory follicle development and by using 2 prostaglandin F2α (PGF) treatments at the end to decrease P4 near TAI. Lactating Holstein cows (n=1,808) were randomly assigned during the cool or hot season of the year to receive TAI (d 0) following 1 of 3 treatments: (1) control: controlled internal drug-release insert + 2mg of E2-benzoate on d -11, PGF on d -4, controlled internal drug-release insert withdrawal + 1.0mg of E2-cypionate on d -2, and TAI on d 0; (2) 2PGF: identical to control protocol with addition of a second PGF treatment on d -2; (3) GnRH: identical to 2PGF protocol with addition of a 100-μg GnRH treatment on d -11. Pregnancy diagnoses were performed on d 32 and 60 after TAI. Season had major effects on many reproductive measures, with cool season greater than hot season in percentage of cows with corpus luteum (CL) at PGF (62.9 vs. 56.2%), ovulatory follicle diameter (15.7 vs. 14.8mm), expression of estrus (86.7 vs. 79.9%), ovulation following the protocol (89.7 vs. 84.3%), and pregnancies per artificial insemination (P/AI; 45.4 vs. 21.4%). The GnRH protocol increased percentage of cows with CL (control=56.9%; 2PGF=55.8%; GnRH=70.5%) and P4 at PGF (control=3.28±0.22; 2PGF=3.35±0.22; GnRH=3.70±0.21ng/mL), compared with control and 2PGF protocols. The GnRH protocol increased P/AI at the pregnancy diagnosis at 32d [37.3% (219/595)] and 60d [31% (179/595)] after TAI, compared with control [30.0% (177/604); 25.1% (145/604)], with intermediate results with 2PGF protocol [33.2% (196/609); 28.0% (164/609)]. The positive effects of GnRH treatment on P/AI were only detected during the cool season (GnRH=50.9%; 2PGF=44.2%; control=41.0%) and not during the hot season. In addition, the effect of GnRH was only observed in cows with low P4 (<3ng/mL) at the start of the protocol and not in cows that began the protocol with high P4. Furthermore, presence of CL at PGF interacted with follicle diameter such that cows with a CL at PGF had greater P/AI if they ovulated larger rather than smaller follicles near TAI. Thus, fertility to TAI can be improved by inducing ovulation at the beginning of an E2/P4-based protocol using GnRH treatment, particularly during the cool season of the year and in cows with low P4 at the start of the protocol.
authors.affiliation: Faculdade de Medicina Veterinária e Zootecnia, Universidade Estadual Paulista (UNESP), Botucatu, SP 18618-000, Brazil.
authors.forename: M H C
authors.initials: MH
authors.lastname: Pereira
authors.affiliation: Department of Dairy Science, University of Wisconsin, Madison 53706.
authors.forename: M C
authors.initials: MC
authors.lastname: Wiltbank
authors.affiliation: Faculdade de Medicina Veterinária e Zootecnia, Universidade Estadual Paulista (UNESP), Botucatu, SP 18618-000, Brazil.
authors.forename: L F S P
authors.initials: LF
authors.lastname: Barbosa
authors.affiliation: Faculdade de Medicina Veterinária e Zootecnia, Universidade Estadual Paulista (UNESP), Botucatu, SP 18618-000, Brazil.
authors.forename: W M
authors.initials: WM
authors.lastname: Costa
authors.affiliation: MCA Veterinary Clinic, Minas Gerais, Passos 37900002, Brazil.
authors.forename: M A P
authors.initials: MA
authors.lastname: Carvalho
authors.affiliation: Department of Animal Production, São Paulo State University, Botucatu 18168-000, Brazil. Electronic address: vasconcelos@fmvz.unesp.br.
authors.forename: J L M
authors.initials: JL
authors.lastname: Vasconcelos
mesh_terms: D000818:Animals; D002417:Cattle; D003338:Corpus Luteum / Q000187:drug effects; D015237:Dinoprost / Q000494:pharmacology*; D004958:Estradiol / Q000494:pharmacology*; D004971:Estrus / Q000187:drug effects; D004973:Estrus Synchronization / Q000379:methods*; D005260:Female; D005298:Fertility / Q000187:drug effects; D007987:Gonadotropin-Releasing Hormone / Q000494:pharmacology; D006062:Gonadotropins; D007315:Insemination, Artificial / Q000379:methods / Q000662:veterinary*; D007774:Lactation; D006080:Ovarian Follicle / Q000187:drug effects; D010060:Ovulation / Q000187:drug effects; D010062:Ovulation Induction; D010120:Oxytocics / Q000494:pharmacology; D011247:Pregnancy; D011374:Progesterone / Q000494:pharmacology; D012098:Reproduction / Q000187:drug effects; D012621:Seasons; D013696:Temperature
chemical_list: D006062:Gonadotropins; D010120:Oxytocics; D007987:Gonadotropin-Releasing Hormone; D011374:Progesterone; D004958:Estradiol; D015237:Dinoprost
keywords: follicle diameter; gonadotropin-releasing hormone; progesterone